Navigation Links
Joslin researcher named first winner of the Manpei Suzuki International Prize for Diabetes Research

BOSTON November 6, 2008 Joslin Diabetes Center today announced that C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research.

"Joslin Diabetes Center is delighted that one of our world-renowned researchers has been named the inaugural winner of such a prestigious award," said Ranch C. Kimball, President and CEO of Joslin. "Dr. Kahn epitomizes the spirit, perseverance and creativity held by all Joslin researchers that is needed to make the scientific advancements toward preventing and ultimately curing diabetes."

According to the Manpei Suzuki Diabetes Foundation, Dr. Kahn was selected to receive the inaugural award in recognition of his many contributions to diabetes research over the past three decades from the discovery of the basic mechanism for how insulin receptors produce a signal in cells to increase their metabolism, to alterations in this signaling process in diabetes and other disease states. He has also generated multiple strains of mice genetically altered in insulin signaling in order to analyze insulin action one tissue and pathway at a time. Dr. Kahn's work has had an enormous impact on the understanding of the mechanism of insulin action and insulin resistance, processes that are fundamental to the worldwide diabetes epidemic.

"I am truly honored to be recognized for this prize as my lab and I to continue to pursue new frontiers in diabetes and obesity research," said Dr. Kahn.

Dr. Kahn will be formally presented with the award, which includes $150,000, at a ceremony in Tokyo on March 10, 2009. He will also deliver a commemorative lecture at the event.

The newly established award, the largest for diabetes research and one of the largest in medicine, commemorates the 15th anniversary of the Manpei Suzuki Diabetes Foundation, which supports diabetes research through both grants and fellowships. According to the Foundation's web site, the International Prize acknowledges individuals for "their original and excellent achievements in diabetes research" and aims "to advance diabetes research that will contribute to the health and welfare of all people."

An internationally recognized researcher, Dr. Kahn was educated at University of Louisville and trained at Washington University and the National Institutes of Health, where he ultimately served as the Section Head of Cellular and Molecular Physiology of the Diabetes Branch.

In 1981, Dr. Kahn came to Harvard Medical School and the Joslin Diabetes Center. He served as Research Director of Joslin from 1981 to 2000, Executive Vice President from 1997 to 2000, and President and Director from 2000 to 2007. In 1984, he was promoted to Professor of Medicine at Harvard, and in 1986 he was awarded the Mary K. Iacocca Professorship. In 2007, he was named Vice Chair of the Joslin Board of Trustees.

Dr. Kahn has received the highest scientific awards of the American Diabetes Association, U.S. Endocrine Society, British Diabetes and Endocrine Societies, Juvenile Diabetes Research Foundation, International Diabetes Federation and American Federation for Clinical Research, as well as many other honors, including election to the National Academy of Sciences and the Institute of Medicine. He chaired the congressionally established Diabetes Research Working Group which developed the plan that resulted in a more than doubling of diabetes research efforts in the U.S. He also holds honorary doctorates from the Universities of Paris, Louisville and Geneva and an honorary professorship from Peking University.


Contact: Kira Jastive
Joslin Diabetes Center

Related medicine news :

1. Joslin study finds restricting insulin doses increases mortality risk
2. Researchers describe how chronic inflammation can lead to stomach cancer
3. Researchers ID Genetic Markers for Esophageal Cancer
4. Opt out system could solve donor organ shortage, says researcher
5. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
6. Cancer requires support from immune system to develop, UT Southwestern researchers report
7. Researchers find new chemical key that could unlock hundreds of new antibiotics
8. Penn researchers find key to Sonic hedgehog control of brain development
9. Temple researchers look for behavioral link between breastfeeding and lower risk of obesity
10. MU researchers advance health communication for at-risk populations
11. Researcher to provide new insight for treating vascular disease
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: